Cargando…
Reduced FRG1 expression promotes angiogenesis via activation of the FGF2‐mediated ERK/AKT pathway
Identifying novel targets that control both tumorigenesis and angiogenesis can aid in developing a more potent anti‐angiogenic therapeutic strategy. We previously reported that reduction of FRG1 is associated with increased p38‐MAPK signaling in prostate cancer and with elevated MEK–ERK signaling in...
Autores principales: | Mukherjee, Bratati, Brahma, Pratush, Mohapatra, Talina, Chawla, Saurabh, Dixit, Manjusha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153342/ https://www.ncbi.nlm.nih.gov/pubmed/36815234 http://dx.doi.org/10.1002/2211-5463.13582 |
Ejemplares similares
-
Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF
por: Mukherjee, Bratati, et al.
Publicado: (2022) -
Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
por: Tiwari, Ankit, et al.
Publicado: (2019) -
A Cost-Effective and Efficient Chick Ex-Ovo CAM Assay Protocol to Assess Angiogenesis
por: Naik, Monali, et al.
Publicado: (2018) -
Role of FRG1 in predicting the overall survivability in cancers using multivariate based optimal model
por: Khan, Rehan, et al.
Publicado: (2021) -
IQ Motif Containing
GTPase Activating Proteins (IQGAPs),
A-Kinase Anchoring Proteins (AKAPs) and Kinase Suppressor of
Ras Proteins (KSRs) in Scaffolding Oncogenic Pathways and Their Therapeutic
Potential
por: Mohapatra, Talina, et al.
Publicado: (2022)